CUE

NASDAQStock

Cue Biopharma, Inc.

$0.28-0.03 (-9.60%)

52-Week Range

$0.24

$1.03

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.55

Volume

1.0M

Avg Volume

757.2K

Performance

-0.78%

-34.23%

-59.06%

YTD

-9.84%

-67.98%

-90.16%

-97.95%

Price Chart

ETF Exposure

CUE is held by 12 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
STSB	iShares Factors US Small Blend Style ETF	0.08%	559	$5K	$7.3M	0.35%
GERM	ETFMG Treatments, Testing and Advancements ETF	0.07%	10,786	$7K	$9.7M	0.68%
SILX	ETFMG Prime 2x Daily Junior Silver Miners ETF	0.00%	13,815	$62K	$5.5M	0.97%
VALT	ETFMG Sit Ultra Short ETF	0.00%	12,191	$34K	$75.4M	0.30%
AVTM	Avantis Total Equity Markets ETF 1	0.00%	324	$105	$803.1M	0.23%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	74	$33	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,669	$1K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	12	$5	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	1,520,020	$509K	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,995	$4K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	689	$312	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	937,432	$314K	$84.10B	0.05%

About CUE ETF Exposure

Cue Biopharma, Inc. (CUE) is held by 12 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $0.28. Investors can gain exposure to CUE through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CUE, sorted by portfolio weight.